2, 3-dihydrobenzo[1, 4] dioxin2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous systeme diseases

Details for Australian Patent Application No. 2008278924 (hide)

Owner Orion Corporation

Inventors Din Belle, David; Rummankko, Petteri; Wohlfahrt, Gerd; Holm, Patrik; Tolvanen, Arto; Karljalainen, Arto

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008278924

PCT Pub. Number WO2009/013390

Priority 60/950,983 20.07.07 US

Filing date 18 July 2008

Wipo publication date 29 January 2009

International Classifications

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/013390 Priority application(s): WO2009/013390

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008278929-A beverage and a method for preparation thereof

2008278919-Device for extracting elements from a cavity